Last quarter (Q3 2022), Tetra Bio-Pharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Tetra Bio-Pharma's net income was $-3.49M. See Tetra Bio-Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Nov 21	Nov 20	Nov 19	Nov 18	Nov 17
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ 67.59K	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ 44.73K	$ ―
Operating Expense	$ 14.71M	$ 24.30M	$ 20.46M	$ 12.95M	$ 11.58M	$ 6.23M
Operating Income	$ -14.71M	$ -24.30M	$ -20.46M	$ -13.08M	$ -11.58M	$ -6.23M
Net Non Operating Interest Income Expense	$ -231.71K	$ 1.79M	$ -98.01K	$ -89.77K	$ -113.96K	$ 487.00
Other Income Expense	$ -27.04M	$ -26.09M	$ 268.47K	$ -224.97K	$ -4.22M	$ -465.36K
Pretax Income	$ -39.02M	$ -52.18M	$ -20.95M	$ -13.08M	$ -7.84M	$ -6.70M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ -351.11K	$ -651.19K	$ -268.47K	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -39.02M	$ -52.18M	$ -15.63M	$ -10.88M	$ -7.57M	$ -6.23M
Basic EPS	$ -0.06	$ -0.12	$ 0.10	$ -0.08	$ -0.05	$ -0.06
Diluted EPS	$ -0.06	$ -0.12	$ 0.10	$ -0.08	$ -0.05	$ -0.06
Basic Average Shares	$ 1.65B	$ 445.70M	$ 258.15M	$ 188.24M	$ 145.69M	$ 107.80M
Diluted Average Shares	$ 1.65B	$ 445.70M	$ 258.15M	$ 188.24M	$ 145.69M	$ 107.80M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ -4.64M	$ -24.30M	$ -20.46M	$ -12.95M	$ -11.58M	$ -6.23M
Net Income From Continuing And Discontinued Operation	$ -39.02M	$ -52.18M	$ -15.63M	$ -10.88M	$ -7.84M	$ -6.70M
Normalized Income	$ -28.20M	$ -14.37M	$ -15.00M	$ -9.36M	$ -9.65M	$ -4.47M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -38.52M	$ -50.28M	$ -20.95M	$ -13.08M	$ -7.84M	$ -6.70M
EBITDA	$ -38.42M	$ -50.17M	$ -20.92M	$ -13.05M	$ -7.84M	$ -6.69M

Currency in USD

Tetra Bio-Pharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing